MedTrace Logo

Evaluation of Integra® Artificial Dermis for the Treatment of Leg Ulcers

NCT01285973 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2015-08-13

No results posted yet for this study

Summary

The aim of this prospective study is to assess the utility of treatment of leg ulcers using a skin substitute, Integra®, assessing the quality of wound skin healing and transcutaneous oxygen pressure in the distal region of the wound.

This is a multi-centre study on 60 patients who have a lower limb ulcer.

Conditions

  • Lower Limb Ulcer

Sponsors & Collaborators

  • Integra LifeSciences Services

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2015-08-31
Completion
2015-08-31

Countries

  • France
  • Greece
  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01285973 on ClinicalTrials.gov